AAPL336.64-3.78 (-1.11%) ▼|ABBV276.47+4.05 (+1.49%) ▲|ABT99.60+1.11 (+1.13%) ▲|ACN209.06+0.70 (+0.34%) ▲|ADBE242.27+1.22 (+0.51%) ▲|AMAT507.03-2.54 (-0.50%) ▼|AMD608.10-12.58 (-2.03%) ▼|AMGN414.87+7.43 (+1.82%) ▲|AMT182.24+15.51 (+9.30%) ▲|AMZN262.43+8.37 (+3.29%) ▲|AVGO361.54+1.40 (+0.39%) ▲|AXP308.17+1.02 (+0.33%) ▲|BA190.37+2.62 (+1.40%) ▲|BAC54.32+0.71 (+1.32%) ▲|BKNG160.34+0.37 (+0.23%) ▲|BLK1,082.39+17.04 (+1.60%) ▲|BMY59.12-0.46 (-0.77%) ▼|BNY142.71-0.90 (-0.63%) ▼|BRK-B515.62+4.57 (+0.89%) ▲|C129.64+1.56 (+1.22%) ▲|CAT800.47+4.29 (+0.54%) ▲|CL88.27+0.17 (+0.19%) ▲|CMCSA20.66-0.55 (-2.59%) ▼|COF199.26-0.14 (-0.07%) ▼|COP134.10-0.09 (-0.07%) ▼|COST946.92-1.00 (-0.11%) ▼|CRM229.13+1.33 (+0.58%) ▲|CSCO118.39+3.50 (+3.05%) ▲|CVS86.16-1.64 (-1.87%) ▼|CVX211.98+0.43 (+0.20%) ▲|DE620.93-31.65 (-4.85%) ▼|DHR219.81+2.35 (+1.08%) ▲|DIS108.05+1.03 (+0.96%) ▲|DUK116.65-0.19 (-0.16%) ▼|EMR161.83+2.77 (+1.74%) ▲|FDX291.71-0.02 (-0.01%) ▼|GD331.27+2.96 (+0.90%) ▲|GE308.20+2.58 (+0.84%) ▲|GEV1,004.73+5.38 (+0.54%) ▲|GILD151.17+4.07 (+2.77%) ▲|GM82.73+0.48 (+0.58%) ▲|GOOG347.86+3.00 (+0.87%) ▲|GOOGL351.66+3.37 (+0.97%) ▲|GS895.32+12.73 (+1.44%) ▲|HD290.74-4.73 (-1.60%) ▼|HON207.73+1.13 (+0.55%) ▲|IBM227.13+0.52 (+0.23%) ▲|INTC104.70-2.38 (-2.22%) ▼|INTU302.75-1.13 (-0.37%) ▼|ISRG423.96+8.55 (+2.06%) ▲|JNJ261.44+4.96 (+1.93%) ▲|JPM332.99+1.57 (+0.47%) ▲|KO88.05+0.28 (+0.32%) ▲|LIN483.73+2.03 (+0.42%) ▲|LLY1,179.27+9.67 (+0.83%) ▲|LMT509.59+1.70 (+0.33%) ▲|LOW186.00-2.85 (-1.51%) ▼|LRCX318.84-1.75 (-0.55%) ▼|MA589.14+15.25 (+2.66%) ▲|MCD235.23-1.67 (-0.70%) ▼|MDLZ60.41-0.26 (-0.43%) ▼|MDT88.48+0.73 (+0.83%) ▲|META718.67-2.22 (-0.31%) ▼|MMM159.96-3.62 (-2.21%) ▼|MO71.68+0.26 (+0.36%) ▲|MRK145.60+3.22 (+2.26%) ▲|MS190.02+2.58 (+1.38%) ▲|MSFT535.07+12.46 (+2.38%) ▲|MU1,029.00-6.84 (-0.66%) ▼|NEE77.38+0.01 (+0.01%) ▲|NFLX70.30-1.27 (-1.77%) ▼|NKE34.71-0.03 (-0.09%) ▼|NOW140.86+1.11 (+0.79%) ▲|NVDA229.28-1.20 (-0.52%) ▼|ORCL141.40+6.21 (+4.59%) ▲|PEP125.97-2.37 (-1.85%) ▼|PFE28.28+0.46 (+1.65%) ▲|PG151.23+0.64 (+0.43%) ▲|PLTR209.05+10.27 (+5.17%) ▲|PM201.19+0.69 (+0.34%) ▲|QCOM175.50-0.51 (-0.29%) ▼|RTX185.97+1.65 (+0.90%) ▲|SBUX90.75-2.46 (-2.64%) ▼|SCHW96.70-0.17 (-0.18%) ▼|SO86.17+0.02 (+0.02%) ▲|SPG199.42-0.19 (-0.10%) ▼|T22.18-2.41 (-9.81%) ▼|TMO658.02+6.04 (+0.93%) ▲|TMUS148.58-22.73 (-13.27%) ▼|TSLA382.70+7.70 (+2.05%) ▲|TXN283.74-4.46 (-1.55%) ▼|UBER71.51+1.27 (+1.81%) ▲|UNH379.30+8.35 (+2.25%) ▲|UNP278.34+0.14 (+0.05%) ▲|UPS94.57+0.44 (+0.47%) ▲|USB57.08+0.05 (+0.09%) ▲|V385.45+10.35 (+2.76%) ▲|VZ41.65-3.99 (-8.75%) ▼|WFC83.55+1.52 (+1.85%) ▲|WMT111.35+0.79 (+0.71%) ▲|XOM168.94+0.44 (+0.26%) ▲|AAPL336.64-3.78 (-1.11%) ▼|ABBV276.47+4.05 (+1.49%) ▲|ABT99.60+1.11 (+1.13%) ▲|ACN209.06+0.70 (+0.34%) ▲|ADBE242.27+1.22 (+0.51%) ▲|AMAT507.03-2.54 (-0.50%) ▼|AMD608.10-12.58 (-2.03%) ▼|AMGN414.87+7.43 (+1.82%) ▲|AMT182.24+15.51 (+9.30%) ▲|AMZN262.43+8.37 (+3.29%) ▲|AVGO361.54+1.40 (+0.39%) ▲|AXP308.17+1.02 (+0.33%) ▲|BA190.37+2.62 (+1.40%) ▲|BAC54.32+0.71 (+1.32%) ▲|BKNG160.34+0.37 (+0.23%) ▲|BLK1,082.39+17.04 (+1.60%) ▲|BMY59.12-0.46 (-0.77%) ▼|BNY142.71-0.90 (-0.63%) ▼|BRK-B515.62+4.57 (+0.89%) ▲|C129.64+1.56 (+1.22%) ▲|CAT800.47+4.29 (+0.54%) ▲|CL88.27+0.17 (+0.19%) ▲|CMCSA20.66-0.55 (-2.59%) ▼|COF199.26-0.14 (-0.07%) ▼|COP134.10-0.09 (-0.07%) ▼|COST946.92-1.00 (-0.11%) ▼|CRM229.13+1.33 (+0.58%) ▲|CSCO118.39+3.50 (+3.05%) ▲|CVS86.16-1.64 (-1.87%) ▼|CVX211.98+0.43 (+0.20%) ▲|DE620.93-31.65 (-4.85%) ▼|DHR219.81+2.35 (+1.08%) ▲|DIS108.05+1.03 (+0.96%) ▲|DUK116.65-0.19 (-0.16%) ▼|EMR161.83+2.77 (+1.74%) ▲|FDX291.71-0.02 (-0.01%) ▼|GD331.27+2.96 (+0.90%) ▲|GE308.20+2.58 (+0.84%) ▲|GEV1,004.73+5.38 (+0.54%) ▲|GILD151.17+4.07 (+2.77%) ▲|GM82.73+0.48 (+0.58%) ▲|GOOG347.86+3.00 (+0.87%) ▲|GOOGL351.66+3.37 (+0.97%) ▲|GS895.32+12.73 (+1.44%) ▲|HD290.74-4.73 (-1.60%) ▼|HON207.73+1.13 (+0.55%) ▲|IBM227.13+0.52 (+0.23%) ▲|INTC104.70-2.38 (-2.22%) ▼|INTU302.75-1.13 (-0.37%) ▼|ISRG423.96+8.55 (+2.06%) ▲|JNJ261.44+4.96 (+1.93%) ▲|JPM332.99+1.57 (+0.47%) ▲|KO88.05+0.28 (+0.32%) ▲|LIN483.73+2.03 (+0.42%) ▲|LLY1,179.27+9.67 (+0.83%) ▲|LMT509.59+1.70 (+0.33%) ▲|LOW186.00-2.85 (-1.51%) ▼|LRCX318.84-1.75 (-0.55%) ▼|MA589.14+15.25 (+2.66%) ▲|MCD235.23-1.67 (-0.70%) ▼|MDLZ60.41-0.26 (-0.43%) ▼|MDT88.48+0.73 (+0.83%) ▲|META718.67-2.22 (-0.31%) ▼|MMM159.96-3.62 (-2.21%) ▼|MO71.68+0.26 (+0.36%) ▲|MRK145.60+3.22 (+2.26%) ▲|MS190.02+2.58 (+1.38%) ▲|MSFT535.07+12.46 (+2.38%) ▲|MU1,029.00-6.84 (-0.66%) ▼|NEE77.38+0.01 (+0.01%) ▲|NFLX70.30-1.27 (-1.77%) ▼|NKE34.71-0.03 (-0.09%) ▼|NOW140.86+1.11 (+0.79%) ▲|NVDA229.28-1.20 (-0.52%) ▼|ORCL141.40+6.21 (+4.59%) ▲|PEP125.97-2.37 (-1.85%) ▼|PFE28.28+0.46 (+1.65%) ▲|PG151.23+0.64 (+0.43%) ▲|PLTR209.05+10.27 (+5.17%) ▲|PM201.19+0.69 (+0.34%) ▲|QCOM175.50-0.51 (-0.29%) ▼|RTX185.97+1.65 (+0.90%) ▲|SBUX90.75-2.46 (-2.64%) ▼|SCHW96.70-0.17 (-0.18%) ▼|SO86.17+0.02 (+0.02%) ▲|SPG199.42-0.19 (-0.10%) ▼|T22.18-2.41 (-9.81%) ▼|TMO658.02+6.04 (+0.93%) ▲|TMUS148.58-22.73 (-13.27%) ▼|TSLA382.70+7.70 (+2.05%) ▲|TXN283.74-4.46 (-1.55%) ▼|UBER71.51+1.27 (+1.81%) ▲|UNH379.30+8.35 (+2.25%) ▲|UNP278.34+0.14 (+0.05%) ▲|UPS94.57+0.44 (+0.47%) ▲|USB57.08+0.05 (+0.09%) ▲|V385.45+10.35 (+2.76%) ▲|VZ41.65-3.99 (-8.75%) ▼|WFC83.55+1.52 (+1.85%) ▲|WMT111.35+0.79 (+0.71%) ▲|XOM168.94+0.44 (+0.26%) ▲|
12.9 C
New York
Monday, October 12, 2026

Tag: source

newssourceFORcompanyinformationcontent1releasesmarket

Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

HONG KONG, July 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully...

ZenaTech acelera la fabricación de ZenaDrone para drones comerciales y de defensa en EE. UU. tras la reciente ley, ‘One Big Beautiful Bill’, órdenes...

VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), un proveedor de soluciones de tecnología empresarial especializado en drones con inteligencia artificial (IA), Drones como un Servicio (DaaS), soluciones empresariales de software como un servicio (SaaS) y computación cuántica, , anuncia hoy que acelerará la expansión de sus instalaciones con sede en Phoenix, Arizona, lo que incluye triplicar la superficie en pies cuadrados, para permitir la fabricación, ensamblaje y pruebas completas de drones en EE. UU. Esta expansión se adelanta a lo previsto debido a las recientes directivas transformadoras de la política estadounidense de la Casa Blanca, el Departamento de Defensa y la recientemente aprobada ‘One Big Beautiful Bill’ que en conjunto han liberado fondos federales para la producción nacional, eliminado las barreras obsoletas de certificación y adquisición, y acelerado el despliegue directamente a las unidades de primera línea sin requerir la certificación Blue o Green UAS (Sistema Aéreo No Tripulado).

The Beach Football League Is Making Magic and Sandcastles at American Dream

Professional Beach Football League and American Dream Partner for Iconic BFL Dream Beach Weekend! WATERTOWN, Conn., July 15, 2025 /PRNewswire/ -- The Beach Football League (BFL)...

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

DONGGUAN, China, July 15, 2025 /PRNewswire/ -- Amid mounting pressures from the ongoing U.S.–China tariff conflict, Chinese manufacturers are accelerating their digital transformation to...

Mega Fortune Company Limited Announces Pricing of $15 Million Initial Public Offering

Hong Kong, July 15, 2025 (GLOBE NEWSWIRE) -- Mega Fortune Company Limited (the “Company” or “MGRT”), an Internet of Things (“IoT”) solution provider in Hong Kong, today announced the pricing of its initial public offering (the “Offering”) of 3,750,000 ordinary shares at a price of $4.00 per share. The ordinary shares have been approved for listing on The Nasdaq Capital Market and are expected to commence trading on July 16, 2025 under the ticker symbol “MGRT.”

Frontera Announces Normal Course Issuer Bid

Frontera May Purchase up to 3,502,962 Common Shares Representing Approximately 5% of the Company's Issued and Outstanding Common Shares CALGARY, AB, July 15, 2025 /CNW/ - Frontera...

Frontera Announces Normal Course Issuer Bid

Frontera May Purchase up to 3,502,962 Common Shares Representing Approximately 5% of the Company's Issued and Outstanding Common Shares CALGARY, AB, July 15, 2025 /PRNewswire/ - Frontera...

RXSIGHT ALERT: Bragar Eagel & Squire, P.C.Announces Investigation into RxSight, Inc. (RXST) and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In RxSight (RXST) To Contact Him Directly To Discuss Their Options

Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility

Beijing, China, July 15, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (Nasdaq: ZJYL) (“Jin Medical”, and together with all its subsidiaries, the “Company”), a Nasdaq-listed provider of rehabilitation medical equipment, announced today that its wholly owned subsidiary, ZhongJin Medical Equipment (Anhui) Co., Ltd. (“Zhongjin Anhui”), has officially launched production at Plant No. 3 of Zhongjin Anhui’s intelligent manufacturing facility in Chuzhou, Anhui, China. With 19 years of expertise in rehabilitation technology, the Company is committed to accelerate the integration of the global rehabilitation device supply chain through its robust production and precision manufacturing capabilities.

Markel appoints Chelsea Jiang as Managing Director – Greater China

SINGAPORE, July 15, 2025 /PRNewswire/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE: MKL), today announced the appointment of Chelsea Jiang...

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for...

TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

TOKYO, July 15, 2025 /PRNewswire/ -- TIER IV, the pioneering force behind the world's first open-source software for autonomous driving, has developed an end-to-end architecture...

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

SHANGHAI, July 15, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for...

PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test

FebriDx® is a first-in-class rapid test that differentiates between bacterial and non-bacterial respiratory infections, offering significant potential to address critical unmet needs in patient...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSource

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers